MARKET

ARGNF

ARGNF

Argen X
OTCPK
803.19
NaN%
Opening 09:30 05/21 EDT
OPEN
--
PREV CLOSE
803.19
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
894.76
52 WEEK LOW
532.40
MARKET CAP
49.70B
P/E (TTM)
35.76
1D
5D
1M
3M
1Y
5Y
1D
Argenx targets 2.5x more VYVGART patients by decade-end as Phase III empasiprubart MMN readout nears 4Q
Seeking Alpha · 05/07 21:12
argenx SE GAAP EPS of $5.52 beats by $0.31, revenue of $1.3B misses by $10M
Seeking Alpha · 05/07 05:11
PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors
Seeking Alpha · 03/16 03:25
Baron International Growth Fund Q4 2025: Contributors, Detractors, And Trades
Seeking Alpha · 02/27 11:50
Artisan Global Discovery Fund Q4 2025 Winners, Laggards, Buys & Sells
Seeking Alpha · 02/26 12:30
argenx SE GAAP EPS of $8.02 beats by $1.70, revenue of $1.29B misses by $10M
Seeking Alpha · 02/26 06:19
Allspring Premier Large Company Growth Fund Q4 2025 Top Contributors And Detractors
Seeking Alpha · 02/24 00:20
Allspring Large Cap Growth Fund Q4 2025 Performance Update
Seeking Alpha · 02/19 05:30
More
About ARGNF
argenx SE, formerly arGEN X BV, is a Netherlands-based biopharmaceutical company. It is primarily engaged in creating and developing a pipeline of differentiated antibody therapeutics for the treatment of severe autoimmune diseases using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes, but is not limited to: Empasiprubart, a complement inhibitor targeting C2, blocking the function of both the classical and lectin pathways, while leaving the alternative pathway intact, ARGX-119 an antagonist to the MuSK receptor with potential in multiple neuromuscular indications.

Webull offers argenx SE stock information, including OTCPK: ARGNF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARGNF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARGNF stock methods without spending real money on the virtual paper trading platform.